All News

An oncology nurse offers people tips on how to find the courage and be better advocates to their loved ones who may be receiving treatment for cancer.

Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for February 2021.

Call volumes increased to jaw-dropping numbers during the beginning of the pandemic, and this cancer survivor hopes that trend continues even after we are out of the pandemic.

It’s always best to have a team of people, whether friends or family, rooting us on as we face whatever challenges come our way.

The Johnson & Johnson vaccine is delivered in a single dose, which is a departure from the two doses required for the already available Pfizer-BioNTech and Moderna vaccines.

A patient with metastatic breast cancer recalls how she’s been told countless times that she’s so brave, so strong and so resilient. Here, she thanks those who have influenced her and helped her be so courageous.

Over the past decade, advances in both diagnostics and therapeutics in a variety of blood cancers have turned certain diseases into chronic conditions.

The agency granted accelerated approval to Pepaxto in combination with dexamethasone in adult patients with relapsed or refractory multiple myeloma, who received at least four prior lines of therapy.

A roundup of some of the latest news and updates for patients with ovarian cancer from CURE®.

Throughout the winter, the FDA has continued to approve several new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

A cancer survivor recalls his experience with a life-threatening infection following surgery to remove his tumor and notes how it influenced his decision to get a COVID-19 vaccine.

From a childhood cancer survivor being named a member of the first all-civilian SpaceX mission to colorectal cancer survivors golfing alongside PGA Tour champions in the Cologuard Classic, here’s what’s happening in the cancer space this week.

Results from the phase 2 KarMMa trial showed that 73% of patients had a response to the CAR-T cell therapy, including 33% who experienced a complete response or better.

Following resection with radiotherapy increased survival rates for patients compared with those who did not receive the additional treatment.

Although most patients reported satisfaction after undergoing a mastectomy without breast reconstruction surgery, 20.7% of women felt that their surgeon was not supportive of their decision to do so.

A brain tumor survivor’s recent onslaught of symptoms caused her to reach out to her neurosurgeon for reassurance that nothing was wrong. An immediate response to bring her in for an MRI caused her heart to sink.

In this episode of the “CURE Talks Cancer” podcast, we spoke with a gynecologic cancer expert about how her sister’s journey with ovarian cancer provided her with a different perspective that would lead to raising awareness for others.

Here is a list of some recent trials that launched within the cancer space in February.

To discuss the projected rise in bladder cancer cases in 2021, CURE® spoke with Bladder Cancer Advocacy Network (BCAN) co-founder Diane Zipursky-Quale, who offered some insight on why the numbers continue to rise, and provides some hope in the form of educational programs offered by her organization.

After a recent poll reported negative experiences among Black and Latinx patients during their cancer care, the National Comprehensive Cancer Network, American Cancer Society Cancer Action Network and National Minority Quality Forum recommended practice changes to prevent racial disparities moving forward.

A caregiver recalls how she and her daughter went to get tattoos to celebrate the end of her daughter’s breast cancer treatment. Now, every time she looks down at her tattoo, she can smile knowing her daughter conquered cancer.

Two evaluations for treatment responses in women with ovarian, fallopian tube or primary peritoneal carcinoma may need to take into consideration other factors such as other existing conditions.

Patients with oropharyngeal cancer demonstrate higher rates of ever performing, timing, number of partners and intensity in oral sex than matching participants, suggesting an association between behavior and diagnosis.

A cancer diagnosis often comes with concerns of what’s next for patients. One concern is how they’re going to afford their treatments. Here, a panel of experts discuss what options are available.

There are two myths that patients with cancer believe when it comes to being health advocates. Here, a panel of experts look to dispel those myths to help patients become better advocates.

A cancer survivor reflects on her decision to receive a COVID-19 vaccine when it was made available to her.

Sending a text message reminder to participants about their upcoming fecal immunochemical test improved previously poor adherence rates for colorectal cancer screening.

Positive results from the phase 3 CLEAR clinical trial, presented at the 2021 ASCO Genitourinary Cancers Symposium, are just one more dataset that could offer “a sense of hope and promise” for patients with advanced renal cell carcinoma (RCC), says the study’s lead author, Dr. Robert J. Motzer.

On social media, CURE® recently asked its readers to share their favorite motivational or inspirational quotes. Here's what they had to share.